Unforeseen consequence: heterotopic ossification following traumatic brain injury and acetabulum fracture-a case report
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20232628Keywords:
HO, Neurological injury, Acetabulum fractureAbstract
Heterotopic ossification (HO) is a rare pathological condition characterized by the formation of bone in soft tissues outside the normal skeletal system. HO can result in restricted joint mobility, nerve compression, and pain. We present a case report of a 34-year-old male who developed HO. There is a history of neurological injury and fracture acetabulum (left). Imaging studies revealed extensive HO with complete bony bridging of the hip joint, leading to severe functional impairment and chronic pain. The patient had previously undergone multiple medical treatments with non-steroidal anti-inflammatory drugs, and physiotherapy with limited success. Ultimately, he underwent a complex surgical intervention involving resection of HO, release of joint contractures, resulting in significant improvement in joint mobility and pain control. Here we discuss a rare and debilitating presentation of HO and the treatment options available for such patients. Clinicians should be aware of this challenging condition and manage patients through a multidisciplinary approach.
Metrics
References
Dejerine A, Ceiller A. Para-osteo-arthropathies des paraplegiques par lesion medullaire: etude clinique et radiographique. Ann Med. 1918;5:497.
Forsberg JA, Pepek JM, Wagner S, Wilson K, Flint J, Andersen RC et al. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg. 2009;91(8):1893-900.
Onder K, Muhammed B, Saime U, Haluk A. Post-traumatic heterotopic ossification of the crus: a case study. Ortopedia Traumatologia Rehabilitacja. 2011;13(3):299-301.
Urist MR, Nakagawa M, Nakata N, Nogami H. Experimental myositis ossificans: cartilage and bone formation in muscle in response to diffusible bone matrix derived morphogen. Arch Pathol Lab Med. 1978;102:312-6.
Chalmers J, Gray DH, Rush J. Observations on the induction of bone in soft tissues. J Bone Joint Surg Br. 1975;57:36-45.
Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev. 1992;32:160e7.
Wang Y, He T, Liu J, Liu H, Zhou L, Hao W. Synergistic effects of overexpression of BMP 2 and TGFbeta3 on osteogenic differentiation of bone marrow mesenchymal stem cells. Mol Med Rep 2016;14:5514e20.
Ho SSW, Stern PJ, Bruno LP. Pharmacological inhibition of prostaglandin E-2 in bone and its effect on pathological new bone formation in a rat brain model. Trans Orthop Res Soc. 1988;13:536.
Lavielle S. Analysis of tachykinin binding site interactions using constrained analogues of tachykinins. Biochem Pharmacol. 1988;37(1):41-9.
Fristad I. NK1, NK2, NK3 and CGRP1 receptors identified in rat oral soft tissues, and in bone and dental hard tissue cells. Cell Tissue Res. 2003;311(3):383-91.
Evans KN, Forsberg JA, Potter BK, Hawksworth JS, Brown TS, Andersen R et al. Inflammatory cytokine and chemokine expression is associated with heterotopic ossification in highenergy penetrating war injuries. J Orthop Trauma. 2012;26:e204.
Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med. 2002;43:346-53.
Saussez S, Blaivie C, Lemort M, Chantrain G. Non-traumatic myositis ossificans in the paraspinal muscles. Europ Arch Oto-Rhino-Laryngol. 2006;263(4):331-5.
Baird EO, Kang QK. Prophylaxis of heterotopic ossification-an updated review. J Orthop Surg Res. 2009;4(1):12.
¬Casavant AM, Hastings H 2nd. Heterotopic ossification about the elbow: a therapist’s guide to evaluation and management. J Hand Ther. 2006;19(2):255-66.